Jill A. Myers
Momenta Pharmaceuticals, USA
Biography
Jill Myers leads CMC efforts in regulatory communications in biosimilars and novel biologics at Momenta Pharmaceuticals. Previously she built an independent consulting firm with multiple operational and strategic projects. Before that she started a process development and manufacturing department at Applied Molecular Evolution and prior to that she was a program executive at and ran the Process Biochemistry group at Biogen. Dr. Myers earned her Ph.D. in Biochemistry from UCLA and was a post-doctoral fellow at Harvard Medical School and has served on multiple industry committees including past Chair of the Board of the Recovery of Biological Products Conference Series.
Abstract
Abstract : Challenges and approaches in demonstrating biosimilarity at the physicochemical and biological level
